Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Psychoneuroendocrinology. 2019 Apr 4;106:195–205. doi: 10.1016/j.psyneuen.2019.04.002

Table 1.

Characteristics of the study sample.

Characteristics Control
(N = 35)
TSST-G
(N = 35)
Group comparison

Age (y) 40.34 (10.76) 36.63 (11.85) F(1,68) = 1.89,ns
BMI 24.64 (3.84) 24.63 (4.08) F(1,68) < 0.01,ns
MBI-GS 2.32 (0.78) 2.11 (0.96) F(1,68) = 0.80,ns
PHQ-9 7.09 (4.18) 7.11 (4.54) F(1,68) = < 0.01,ns
HCC 16.28 (13.36) 20.49 (18.94) F(1,35) = 0.63,ns
Salivary cortisol (baseline) 4.89 (3.20) 6.22 (7.89) F(1,68) = 0.86,ns
sAA (baseline) 119.80 (77.42) 147.56 (99.35) F(1,68) = 1.70,ns
HR (seated baseline) 71.04 (8.83) 73.19 (10.52) F(1,68) = 0.85,ns
VmHRV (seated baseline) 35.32 (29.24) 32.35 (19.55) F(1,68) = 0.25,ns
Mean VAS (baseline) 1.48 (1.22) 2.14 (1.61) F(1,68) = 3.75,ns
PASA
 Primary appraisal 2.71 (0.67) 3.60 (0.87) F(1,68) = 22.78,s
   Secondary 3.95 (0.66) 4.40 (0.72) F(1,68) = 7.32,s
  appraisal −1.24 (1.05) −0.80 (1.21) F(1,68) = 2.67,ns
   Stress index

Note. BMI = body mass index; HCC = hair cortisol concentration; HR = mean heart rate; MBI-GS = Maslach Burnout Inventory - General Survey sum-score, burnout symptoms; Mean VAS = mean value of six visual analogue scales; PASA = Primary Appraisal - Secondary Appraisal questionnaire; PHQ-9 = Patient Health Questionnaire sum-score, depressive symptoms; sAA = salivary alpha-amylase; vmHRV vagally-mediated heart rate variability; Cells indicate mean with SD in parentheses.